Sector: MedicalMedImmune, Inc. (NASDAQ: MEDI)
Headlines
- Federal Circuit Affirms Dismissal of Declaratory Judgment Counterclaims in Trusopt/Cosopt Case
Oct 10, 2008 10:45 AM | HITK, MEDI, MRK
- Federal Circuit Affirms Dismissal of Prasco's Declaratory Judgment Suit Against Medicis
Oct 07, 2008 12:52 PM | MEDI
- Another Seal of Approval For Micromet
Aug 19, 2008 10:52 AM | AZN, CLDA, IMGN, MEDI, MITI, SNY
- American On Sale
Jul 25, 2008 11:50 AM | BUD, CBH, CGI, DNA, HBHC, IPS
- Periodicals Wrap-Up for Friday, May 23rd
May 23, 2008 09:27 AM | AAPL, AGU, AMR, ATVI, AZN, BHI
- Analyst Comments: Stoneridge, Array Pharma, Finisar, Infinity Pharma, CombinatoRx, Ness Tech, Human Genome
May 06, 2008 04:53 PM | ACN, ARRY, CRXX, CSC, EDS, FNSR
- District Court Dismisses Impax's Declaratory Judgment Complaint in ANDA Case Against Medicis
Apr 25, 2008 01:06 AM | DNA, MEDI, MMC
- AstraZeneca is Waiting to be Found by Investors
Mar 22, 2008 04:47 PM | AZN, MDCO, MEDI, PFE
- Big Pharma?s Expected Revenues
Jul 11, 2007 09:11 PM | ABT, AZN, BIIB, BMY, BSX, CELG
- Oxygen Breakthrough Interview Now Available on MN1.com and Invitrogen Launches New Engineered Stem Cell Line
Jun 18, 2007 09:30 AM | IVGN, MEDI, MEDX
Analyst Ratings
Sentiment Survey
|
|
|
|
|
|
|
|
|
|
|
Share Performance
|
Period
|
MEDI
|
Compare to S&P
|
| YTD |
-0.01 %
|
65.61 %
|
| 4 Weeks |
-0.01 %
|
-0.01 %
|
| 12 Weeks |
-0.01 %
|
-0.01 %
|
|
Financial Ratios
Earnings Performance
|
EPS Growth in Last Quarter: 32.00 %
|
|
EPS Growth in Last Year: 186.96 %
|
|
Sales Growth in Last Quarter: 8.72 %
|
|
Sales Growth in Last Quarter: 15.42 %
|
|
